CTI BIOPHARMA CORP's ticker is and the CUSIP is 12648L906. A total of 4 filers reported holding CTI BIOPHARMA CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,000 | -33.3% | 5,000 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | -99.0% | 5,000 | -98.0% | 0.00% | -100.0% |
| Q4 2015 | $305,000 | -17.8% | 247,700 | -2.5% | 0.00% | -20.0% |
| Q3 2015 | $371,000 | -25.8% | 254,100 | -1.0% | 0.01% | -28.6% |
| Q2 2015 | $500,000 | -44.9% | 256,600 | -48.8% | 0.01% | -50.0% |
| Q1 2015 | $908,000 | +14.5% | 501,600 | +49.3% | 0.01% | +16.7% |
| Q4 2014 | $793,000 | -9.7% | 335,900 | -7.4% | 0.01% | -14.3% |
| Q3 2014 | $878,000 | +73.2% | 362,700 | +100.8% | 0.01% | +75.0% |
| Q2 2014 | $507,000 | – | 180,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 1,200 | $17,000 | 0.00% |